Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 12, 2025 09:49 ET | Source: Faruqi & Faruqi LLP

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Biohaven To Contact Him Directly To Discuss Their Options If you purchased or...
September 11, 2025 07:43 ET | Source: Bragar Eagel & Squire

BIOHAVEN FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Biohaven Investors of the September 12th Deadline to File in the Class Action Lawsuit

The complaint alleges Biohaven overstated troriluzole’s approval chances and BHV-7000’s efficacy, misleading investors on its business and prospects.
September 09, 2025 17:40 ET | Source: Bragar Eagel & Squire

BIOHAVEN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Biohaven Investors of the September 12th Deadline to File in the Class Action Lawsuit

Complaint alleges Biohaven overstated prospects for troriluzole and BHV-7000, making false statements that misled investors on its business.
September 07, 2025 11:16 ET | Source: Faruqi & Faruqi LLP

Faruqi & Faruqi Reminds Biohaven Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 12, 2025 - BHVN

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Biohaven To Contact Him Directly To Discuss Their Options If you purchased or...
September 07, 2025 10:44 ET | Source: Bragar Eagel & Squire

BIOHAVEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Biohaven Ltd. and Encourages Investors to Contact the Firm

Biohaven allegedly overstated prospects of troriluzole and BHV-7000; disclosure of setbacks harmed business outlook and investor confidence.
September 03, 2025 08:20 ET | Source: Faruqi & Faruqi LLP

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Biohaven To Contact Him Directly To Discuss Their Options If you purchased or...
September 03, 2025 08:07 ET | Source: Bragar Eagel & Squire

BIOHAVEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Biohaven Ltd. and Encourages Investors to Contact the Firm

Allegedly, Biohaven overstated the prospects of troriluzole and BHV-7000, misleading investors and exposing the company to significant financial risk.
August 30, 2025 08:10 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Urges Investors in XPLR Infrastructure, Centene, Biohaven, or Capricor to Inquire About Their Rights in Class Action Lawsuits

If you purchased or acquired securities in any of the above companies during their class period and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or...
August 26, 2025 08:50 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Urges Investors in XPLR Infrastructure, Centene, Biohaven, or Capricor to Inquire About Their Rights in Class Action Lawsuits

If you purchased or acquired securities in any of the above companies during their class period and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or...
August 21, 2025 17:01 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Urges Investors in XPLR Infrastructure, Centene, Biohaven, or Capricor to Inquire About Their Rights in Class Action Lawsuits

If you purchased or acquired securities in any of the above companies during their class period and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or...